Next Article in Journal
The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock
Next Article in Special Issue
Role of Phospholipase A2 in Retrograde Transport of Ricin
Previous Article in Journal
Modified Heat-Stable Toxins (hSTa) of Enterotoxigenic Escherichia coli Lose Toxicity but Display Antigenicity after Being Genetically Fused to Heat-Labile Toxoid LT(R192G)
Previous Article in Special Issue
Role of the Mannose Receptor (CD206) in Innate Immunity to Ricin Toxin
Article Menu

Export Article

Open AccessArticle
Toxins 2011, 3(9), 1163-1184;

Passive and Active Vaccination Strategies to Prevent Ricin Poisoning

Children’s Hospital and LSU Health Sciences Center, New Orleans, LA 70118, USA
Cancer Immunobiology Center and Department of Microbiology, University of Texas, Southwestern Medical Center, Dallas, TX 75235, USA
Children’s Hospital, New Orleans, LA 70118, USA
Cangene Corporation, Winnipeg, MB R3T 5Y3, Canada
Cancer Immunobiology Center, Departments Of Immunology and Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75230, USA
Author to whom correspondence should be addressed.
Received: 18 July 2011 / Revised: 17 August 2011 / Accepted: 5 September 2011 / Published: 15 September 2011
(This article belongs to the Special Issue Ricin Toxin)
Full-Text   |   PDF [804 KB, uploaded 15 September 2011]   |  


Ricin toxin (RT) is derived from castor beans, produced by the plant Ricinus communis. RT and its toxic A chain (RTA) have been used therapeutically to arm ligands that target disease-causing cells. In most cases these ligands are cell-binding monoclonal antibodies (MAbs). These ligand-toxin conjugates or immunotoxins (ITs) have shown success in clinical trials [1]. Ricin is also of concern in biodefense and has been classified by the CDC as a Class B biothreat. Virtually all reports of RT poisoning have been due to ingestion of castor beans, since they grow abundantly throughout the world and are readily available. RT is easily purified and stable, and is not difficult to weaponize. RT must be considered during any “white powder” incident and there have been documented cases of its use in espionage [2,3]. The clinical syndrome resulting from ricin intoxication is dependent upon the route of exposure. Countermeasures to prevent ricin poisoning are being developed and their use will depend upon whether military or civilian populations are at risk of exposure. In this review we will discuss ricin toxin, its cellular mode of action, the clinical syndromes that occur following exposure and the development of pre- and post-exposure approaches to prevent of intoxication. View Full-Text
Keywords: ricin; biothreat; vaccines; antibodies ricin; biothreat; vaccines; antibodies

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Pincus, S.H.; Smallshaw, J.E.; Song, K.; Berry, J.; Vitetta, E.S. Passive and Active Vaccination Strategies to Prevent Ricin Poisoning. Toxins 2011, 3, 1163-1184.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top